Viemed (VMD) Director Randy Dobbs Exercises Units, Sells 4,191 Shares

What Happened

• Randy E. Dobbs, a director of Viemed Healthcare (VMD), had multiple equity unit transactions reported August 19, 2026. Phantom-share units and RSUs vested/converted: totals of 16,763 and 4,191 shares were reported as exercised/converted (derivative "M" transactions). Concurrently, 4,191 of the underlying shares were disposed to the issuer at $8.94 per share for $37,468. Dobbs was also granted 16,848 RSUs on August 17, 2026 (vest on first anniversary).

Key Details

• Transaction dates: Grant on 2026-08-17; conversions/dispositions on 2026-08-19.
• Sale to issuer: 4,191 shares disposed to company at $8.94 each = $37,468.
• Other derivative entries show exercise/conversion and zero per-share price ($0.00) — these reflect derivative unit settlements, not open-market sales.
• Grant: 16,848 RSUs awarded 2026-08-17 that vest on the first anniversary (per footnote).
• Footnotes: RSUs = 1 share each (F1); phantom shares were cash‑settled and reported as acquisition of underlying shares with a simultaneous disposition of those shares to the Company for cash (F2); per‑share value uses 8/19/2026 closing price where noted (F3).
• Shares owned after transaction: Not specified in the Form 4 filing.
• Filing timeliness: Report filed 2026-08-19 for transactions on 8/17 and 8/19 — appears to be filed within the normal reporting window.

Context

• The filing reflects derivative unit vesting/settlement and a company buyback/settlement rather than an open‑market sale. Footnote F2 indicates the phantom shares were cash‑settled (economic equivalent of shares) and the reporting shows both the acquisition of underlying shares and the simultaneous disposition of those shares to the company for cash — common for cash‑settled awards or tax‑withholding. These actions are routine compensation/settlement events and do not necessarily signal a change in insider sentiment.